Literature DB >> 12740340

Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon.

D Berrebi1, R Maudinas, J-P Hugot, M Chamaillard, F Chareyre, P De Lagausie, C Yang, P Desreumaux, M Giovannini, J-P Cézard, H Zouali, D Emilie, M Peuchmaur.   

Abstract

BACKGROUND: Crohn's disease is one of the principal human chronic inflammatory bowel diseases. Although its aetiology is still unknown, its complex pathogenesis has environmental, immunological, and genetic determinants. CARD15 is the first susceptibility gene implicated in the predisposition to Crohn's disease and is known to be expressed only in monocytes. However, its expression in situ has not yet been studied. AIMS: To analyse the tissue distribution of CARD15 and identify cells producing CARD15 in samples of colon from patients with Crohn's disease and control subjects. PATIENTS AND METHODS: We analysed CARD15 gene expression in surgical specimens of colon from eight children with Crohn's disease and nine controls by immunohistochemistry, in situ hybridisation, and reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: We showed that CARD15 was present only in the cytoplasm of macrophages in the normal colon. Increased CARD15 expression was detected in Crohn's disease lesions. There were more CARD15 positive cells in Crohn's disease lesions than in uninvolved areas. Both intestinal epithelial cells, macrophages, and their derivatives overproduced CARD15 in Crohn's disease. To further assess CARD15 expression by intestinal epithelial cells, we performed RT-PCR on freshly isolated intestinal epithelial cells, and showed that these cells isolated from Crohn's disease samples contained more CARD15 mRNA than intestinal epithelial cells from controls.
CONCLUSIONS: We have demonstrated that colonic involvement in active Crohn's disease is associated with increased CARD15 gene expression in both macrophages and intestinal epithelial cells. Therefore, this deregulation can affect the host-environment interaction and thus contribute to the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740340      PMCID: PMC1773666          DOI: 10.1136/gut.52.6.840

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

Review 1.  Crohn's disease.

Authors:  Fergus Shanahan
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

2.  The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease.

Authors:  M Radlmayr; H P Török; K Martin; C Folwaczny
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

3.  The molecular classification of the clinical manifestations of Crohn's disease.

Authors:  Tariq Ahmad; Alessandro Armuzzi; Mike Bunce; Kim Mulcahy-Hawes; Sara E Marshall; Timothy R Orchard; Jonathan Crawshaw; Oliver Large; Arjuna de Silva; Julia T Cook; Martin Barnardo; Sue Cullen; Ken I Welsh; Derek P Jewell
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

4.  Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.

Authors:  Mathias Chamaillard; Dana Philpott; Stephen E Girardin; Habib Zouali; Suzanne Lesage; Fabrice Chareyre; The Hung Bui; Marco Giovannini; Ulrich Zaehringer; Virginie Penard-Lacronique; Philippe J Sansonetti; Jean-Pierre Hugot; Gilles Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

Review 5.  Review article: the immunoregulatory cytokine interleukin-10--a therapy for Crohn's disease?

Authors:  J O Lindsay; H J Hodgson
Journal:  Aliment Pharmacol Ther       Date:  2001-11       Impact factor: 8.171

6.  Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study.

Authors:  Jochen Hampe; Jochen Grebe; Susanna Nikolaus; Camilla Solberg; Peter J P Croucher; Silvia Mascheretti; Jörgen Jahnsen; Björn Moum; Bodo Klump; Michael Krawczak; Muddassar M Mirza; Ulrich R Foelsch; Morten Vatn; Stefan Schreiber
Journal:  Lancet       Date:  2002-05-11       Impact factor: 79.321

7.  RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.

Authors:  Koichi Kobayashi; Naohiro Inohara; Lorraine D Hernandez; Jorge E Galán; Gabriel Núñez; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

8.  TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection.

Authors:  Daniel R Roach; Andrew G D Bean; Caroline Demangel; Malcolm P France; Helen Briscoe; Warwick J Britton
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation.

Authors:  Olga Gutierrez; Carlos Pipaon; Naohiro Inohara; Ana Fontalba; Yasunori Ogura; Felipe Prosper; Gabriel Nunez; Jose L Fernandez-Luna
Journal:  J Biol Chem       Date:  2002-08-22       Impact factor: 5.157

10.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

Authors:  Andrew P Cuthbert; Sheila A Fisher; Muddassar M Mirza; Kathy King; Jochen Hampe; Peter J P Croucher; Silvia Mascheretti; Jeremy Sanderson; Alastair Forbes; John Mansfield; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

View more
  40 in total

1.  RICK/RIP2 is a NOD2-independent nodal point of gut inflammation.

Authors:  Tomohiro Watanabe; Kosuke Minaga; Ken Kamata; Toshiharu Sakurai; Yoriaki Komeda; Tomoyuki Nagai; Atsushi Kitani; Masaki Tajima; Ivan J Fuss; Masatoshi Kudo; Warren Strober
Journal:  Int Immunol       Date:  2019-09-18       Impact factor: 4.823

2.  NOD2 modulates immune tolerance via the GM-CSF-dependent generation of CD103+ dendritic cells.

Authors:  David Prescott; Charles Maisonneuve; Jitender Yadav; Stephen J Rubino; Stephen E Girardin; Dana J Philpott
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-29       Impact factor: 11.205

Review 3.  Genotypes and phenotypes in Crohn's disease: do they help in clinical management?

Authors:  C Gasche; P Grundtner
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 4.  Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.

Authors:  E Cario
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

Review 5.  Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.

Authors:  D S A Sanders
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

Review 6.  Novel pathophysiological concepts of inflammatory bowel disease.

Authors:  Toshifumi Hibi; Haruhiko Ogata
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

7.  Distribution of common CARD15 variants in patients with sporadic Crohn's disease: cases from Turkey.

Authors:  F Aytül Uyar; Hülya Over-Hamzaoğlu; Filiz Türe; Ahmet Gül; Nurdan Tözün; Güher Saruhan-Direskeneli
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

Review 8.  Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation.

Authors:  L Ferrero-Miliani; O H Nielsen; P S Andersen; S E Girardin
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 9.  Hematopoietic cell transplantation for Crohn's disease; is it time?

Authors:  Y Leung; M Geddes; J Storek; R Panaccione; P L Beck
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

10.  Evidence for the involvement of NOD2 in regulating colonic epithelial cell growth and survival.

Authors:  Sheena-M Cruickshank; Louise Wakenshaw; John Cardone; Peter-D Howdle; Peter-J Murray; Simon-R Carding
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.